Clinical Trials in Portland

Showing 4761-4780 of 10,048 trials

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

NCT04828590

DEEPVESSEL FFR is a medical device that is designed to extract three- dimensional coronary tree structures and generate computed tomography-derived fraction flow reserve (FFR) values from coronary CT angiogram images. The primary objective of this multi-center clinical validation study is to validate the clinical performance of DEEPVESSEL FFR in identifying patients with myocardial ischemia due to significant obstructive coronary artery diseases.

Coronary Artery DiseaseMyocardial Ischemia

Keya Medical302 participantsStarted Aug 2020

Fort Lauderdale, Florida, United States • Kansas City, Kansas, United States • Portland, Oregon, United States +7 more locations

COMPLETEDPhase 3< 1 mile

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

NCT00605215

The study aims to compare the effect of daily oral treatment of laquinimod capsules 0.6 milligrams (mg) with the effect of placebo capsules (capsules that contain no active medication) as well as with the effect of an existing Multiple Sclerosis (MS) injectable drug: Interferon β-1a (Avonex®).

Multiple Sclerosis

Teva Branded Pharmaceutical Products R&D, Inc.1,331 participantsStarted Apr 2008

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +167 more locations

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

Find Trials by Condition in Portland

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

The Product Surveillance Registry REVERSE Post Approval Study

Supported Employment Demonstration

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

Reconnecting: Improving Interoception to Reduce Suicidal Ideation in the Military

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

Clinical Study to Evaluate CryoBalloon™ Full and Swipe Ablation Systems for Ablation of Human Esophageal Epithelium

Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

Study to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis